Merck (MRK) is one of the largest international healthcare companies, focusing on delivering innovative health solutions through its prescription medicines, vaccines, biologic therapies, animal health products, and other related pharmaceuticals. Since completing its spinoff with women's health company Organon in June, the company's operations are mainly split into two segments, which are the Pharmaceutical and Animal Health segments, both of which are reportable. Merck's diversified portfolio of pharmaceuticals and animal health medicines comprises a great stream of cash flows for the company. Merck is highly profitable, offering a strong dividend, while the stock is trading at an attractive valuation multiple. For this reason, I am bullish on the stock.
https://www.tipranks.com/news/article/merck-stock-attractive-dividend-play-at-current-levels?utm_source=advfn.com&utm_medium=referral
Merck (NYSE:MRK)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Merck Charts.